```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 10396 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                               H. R. 10396

To amend title 38, United States Code, to ensure that the Secretary of 
   Veterans Affairs furnishes certain non-opioid pain medications to 
                   veterans, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           December 12, 2024

 Mr. Landsman (for himself and Mr. Van Orden) introduced the following 
     bill; which was referred to the Committee on Veterans' Affairs

_______________________________________________________________________

                                 A BILL

 
To amend title 38, United States Code, to ensure that the Secretary of 
   Veterans Affairs furnishes certain non-opioid pain medications to 
                   veterans, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``NOPAIN for Veterans Act''.

SEC. 2. INCLUSION OF CERTAIN NON-OPIOID PAIN MEDICATIONS IN THE 
              NATIONAL FORMULARY OF THE DEPARTMENT OF VETERANS AFFAIRS.

    (a) In General.--Section 8125 of title 38, United States Code, is 
amended--
            (1) in subsection (d), by adding at the end the following 
        new paragraph:
            ``(4) The term `non-opioid pain management drug or 
        biological product' means a drug or biological product 
        approved, granted, or cleared by the Food and Drug 
        Administration to reduce postoperative pain, or to produce 
        postsurgical or regional analgesia, without acting upon the 
        body's opioid receptors.''.
            (2) by redesignating subsection (d), as so amended, as 
        subsection (e); and
            (3) by inserting, after subsection (c), the following new 
        subsection (d):
    ``(d) The Secretary shall--
            ``(1) not later than one year after the date on which a 
        non-opioid pain management drug or biological product becomes 
        eligible for temporary additional payment under section 
        1833(t)(16)(G) of the Social Security Act (42 U.S.C. 
        1395l(t)(16)(G)), or eligible for separate payment under 
        section 416.174 of title 42, Code of Federal Regulations (or 
        successor regulation), include such non-opioid pain management 
        drug or biological product in the national formulary of the 
        Department; and
            ``(2) include a non-opioid pain management drug or 
        biological product in the drug standardization list of the 
        Department.''.
    (b) Limitation.--None of the funds in the Cost of War Toxic 
Exposures Fund under section 324 of title 38, United States Code, may 
be used to carry out the amendments made by this section.
    (c) Implementation.--Not later than 90 days after the date of the 
enactment of this Act, the Secretary of Veterans Affairs shall 
implement the amendments made by this section.
                                 <all>
```